Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 18 (6) , 771-779
- https://doi.org/10.1016/j.sbi.2008.10.001
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Specific pathogen free conditions prevent transthyretin amyloidosis in mouse modelsTransgenic Research, 2008
- Adapting Proteostasis for Disease InterventionScience, 2008
- Misfolding of the Cystic Fibrosis Transmembrane Conductance Regulator and DiseaseBiochemistry, 2008
- Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug designBiochemical Journal, 2007
- Protein Misfolding, Functional Amyloid, and Human DiseaseAnnual Review of Biochemistry, 2006
- Proteomics of β2-microglobulin amyloid fibrilsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005
- Folding proteins in fatal waysNature, 2003
- Molecular Mechanisms of AmyloidosisNew England Journal of Medicine, 2003
- Removal of the N‐terminal hexapeptide from human β2‐microglobulin facilitates protein aggregation and fibril formationProtein Science, 2000
- β 2‐microglobulin can be refolded into a native state from ex vivo amyloid fibrilsEuropean Journal of Biochemistry, 1998